Cytoskeletal alterations in human platelets exposed to oxidative stress are mediated by oxidative and Ca2+-dependent mechanisms.
The metabolism of the redox-active quinone, menadione (2-methyl-1,4-naphthoquinone), in human platelets was associated with superoxide anion production, oxidation and depletion of intracellular glutathione, and modification of protein thiols. The cytoskeletal fraction extracted from menadione-treated platelets exhibited a dose-dependent increase in the amount of cytoskeleton-associated protein and a concomitant loss of protein thiols. These alterations were associated with oxidative modifications of actin, including beta-mercaptoethanol-sensitive crosslinking of actin to form dimers, trimers, and high-molecular-weight aggregates which also contained other cytoskeletal proteins, i.e., alpha-actinin and actin-binding protein. In addition, analysis of the cytoskeletal fraction from platelets treated with high concentrations (greater than or equal to 100 microM) of menadione by polyacrylamide gel electrophoresis under reducing conditions revealed a net decrease in the relative abundance of the individual cytoskeletal polypeptides. Under the same incubation conditions the platelets exhibited a sustained increase in cytosolic Ca2+ concentration. The presence of glucose, or the omission of Ca2+ from the incubation medium, prevented both the increase in cytosolic Ca2+ and the decrease in the relative amounts of cytoskeletal proteins. The latter effect was also largely prevented in platelets loaded with Quin-2 tetraacetoxymethyl ester to buffer the menadione-induced elevation of cytosolic Ca2+. Finally, the presence of a protease inhibitor, leupeptin, in the incubation medium prevented the menadione-induced decrease in the amount of actin-binding protein but not the decrease in the other cytoskeletal proteins. Our findings demonstrate that the multiple effects of oxidative stress on the platelet cytoskeleton are mediated by oxidative as well as by Ca2+-dependent mechanisms.
Mirabelli
F
F
Dipartimento di Medicina Interna e Terapia Medica, University of Pavia, Italy.
Salis
A
A
Vairetti
M
M
Bellomo
G
G
Thor
H
H
Orrenius
S
S
D000199:Actins / Q000378:metabolism; D000255:Adenosine Triphosphate / Q000378:metabolism; D001792:Blood Platelets / Q000187:drug effects / Q000378:metabolism*; D002118:Calcium / Q000378:metabolism*; D002458:Cell Fractionation; D003599:Cytoskeleton / Q000187:drug effects / Q000378:metabolism*; D003600:Cytosol / Q000378:metabolism; D006801:Humans; D008840:Microfilament Proteins / Q000378:metabolism; D010084:Oxidation-Reduction / Q000187:drug effects; D010455:Peptides / Q000378:metabolism; D013481:Superoxides / Q000096:biosynthesis; D014812:Vitamin K / Q000494:pharmacology*
D000199:Actins; D008840:Microfilament Proteins; D010455:Peptides; D013481:Superoxides; D014812:Vitamin K; D000255:Adenosine Triphosphate; D002118:Calcium